ScholarWorks@Gyeongsang National University: Bae, Eun Young

Detailed Information

Bae, Eun Young (배은영)

약학대학 (약학과)

Research Area

Tel 0557722431
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

South Korea:4||Economic evaluation:4||암:3||우선순위:3||자원배분:3||priority setting:3||resource allocation:2||Health technology assessment:2||severity:2||의사결정:2||Drug reimbursement:2||Health care rationing:2||health technology assessment:2||decision making:2||지불의사:2||ICER:2||uncertainty:2||Costeffectiveness:2||Cancer:2||암환자:2||기회비용:2||EVIDEM:2||Medical devices:1||Multiplecriteria decision analysis:1||NICE:1||Needs:1||Official compendia:1||Opportunity Cost:1||Potential cures:1||Preferences:1||Priority setting:1||Prioritysetting:1||Qualitative Study:1||Qualityadjusted life years:1||Rarity:1||Reimbursement:1||Risk sharing arrangement:1||Social preference:1||Survival Stage:1||Time to death:1||Value:1||Willingness to Pay:1||age:1||cancer:1||cancer patients:1||catastrophic health expenditure:1||cost of illness:1||costeffectiveness analysis:1||coverage:1||dental implant service:1||determinants:1||disease burden:1||drug policy:1||drugeluting stent:1||economic evaluation:1||endoflife:1||fair innings:1||glaucoma:1||incremental cost effectiveness ratio:1||marginal productivity:1||opportunity costs:1||parametric uncertainty:1||prioritysetting:1||rationing health care:1||risk sharing:1||s Jury:1||sensitivity analysis:1||social solidarity:1||social value:1||structural uncertainty:1||systematic review:1||value of information:1||간병비용:1||결정요인:1||공정수명:1||과부담의료비:1||교통비용:1||녹내장:1||다기준결정분석:1||말기질환:1||보건의료자원배분:1||불확실성:1||비용효과 분석:1||비용효과 임계값:1||사망 전 의료비:1||사회적 가치:1||사회적 연대:1||사회적지지:1||생애말기:1||생존단계:1||약물방출스텐트:1||연령:1||위증도:1||위험분담:1||의료기술평가:1||의료비:1||의료비용:1||재난적 의료비:1||정보의 가치:1||중증도:1||질병비용:1||질적 연구:1||체계적 문헌고찰:1||필요:1||한계 생산성:1||핵심용어: 비용효과 임계값:1||#8217:1||환자시간 비용:1||Access to new drugs:1||Accountability:1||Age factors:1||Cancer Survivor:1||Cancer care cost:1||China:1||Citizen&:1||CostEffectiveness Threshold:1||Costeffectiveness analysis:1||Crude drugs:1||Discrete choice experiment:1||End of Life:1||End of life:1||Gene therapies:1||Health technologies:1||Highpriced:1||International comparison:1||Japan:1||Key Words : costeffectiveness threshold:1||Korea:1||Managed entry agreements:1||

STATISTICS: Total View :6,263,396; Today View :1,186

RSS_1.0 RSS_2.0 ATOM_1.0

Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0533

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE